Escient Pharmaceuticals is a biotech company specializing in the treatment of neurosensory-inflammatory disorders. Escient’s therapeutic programs apply state-of-the-art chemistries and biological understanding for its highly differentiated treatments using a novel class of cellular receptors called Mass-related G protein-coupled receptors (MRGPRS) that can detect and target a broad range of neuro-diseases.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
11/28/2022 | Series C | $120MM | $xx.xx | $256.49MM | 5am Ventures, Abingworth, Altitude Life Science Ventures, Avego, Cowen Healthcare Investments, Forge Life Science Partners, Nea, Osage University Partners, Pfm Health Sciences, Redmile Group, Sanofi Ventures, The Column Group, The Eleven Fund | |
Price per Share
$xx.xx
Shares Outstanding
160,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
5am Ventures, Abingworth, Altitude Life Science Ventures, Avego, Cowen Healthcare Investments, Forge Life Science Partners, Nea, Osage University Partners, Pfm Health Sciences, Redmile Group, Sanofi Ventures, The Column Group, The Eleven Fund
|
||||||
09/14/2020 | Series B | $82.96MM | $xx.xx | $178.2MM | 5am Ventures, Cowen Healthcare Investments, Osage University Partners, Perceptive Advisors, Redmile Group, Sanofi Ventures, The Column Group | |
Price per Share
$xx.xx
Shares Outstanding
66,371,941
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
5am Ventures, Cowen Healthcare Investments, Osage University Partners, Perceptive Advisors, Redmile Group, Sanofi Ventures, The Column Group
|
||||||
05/09/2018 | Series A | $40.55MM | $xx.xx | $67.58MM | 5am Ventures, Osage University Partners, The Column Group | |
Price per Share
$xx.xx
Shares Outstanding
40,546,205
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
5am Ventures, Osage University Partners, The Column Group
|